Medical IV Therapy in Medellín: What's Actually in Your Drip? — A 2026 Patient's Guide to NAD+, Myers Cocktail, High-Dose Vitamin C, Glutathione, Amino Acid, Phosphatidylcholine, and Chelation Protocols, Compounding Pharmacy Verification (INVIMA), G6PD and Renal Pre-Screening, the Eight Bedside IV Questions, and the Distinction Between Clinical Regenerative IV Nutritional Therapy and Mobile Hangover IV Services in Colombia

Introduction: The Two Different IV Worlds in Medellín

There are two different IV worlds in Medellín that share a delivery route and almost nothing else.

The first is the mobile hangover IV economy — nightlife-adjacent mobile services that deliver a saline-plus-vitamin cocktail to a hotel room or short-term rental, marketed for symptomatic recovery from alcohol consumption, with little clinical oversight beyond the IV start, no compounding-pharmacy traceability, no pre-screening, and no clinical indication beyond same-day symptomatic relief.

The second is medical-grade IV nutritional therapy at a regenerative clinic — indication-driven protocols using INVIMA-registered compounded preparations from documented sources, administered by clinical staff with appropriate pre-screening (G6PD for high-dose vitamin C, renal function for NAD+ and high-volume protocols, cardiac history for chelation), sterility validation, drip-rate protocols (NAD+ infused slowly to manage the niacin-flush-equivalent reaction; high-dose vitamin C infused over hours rather than minutes), and adverse-event tracking infrastructure.

Both call themselves "IV therapy." They are not the same product category.

This 2026 patient-protection guide is the autologous-fluids transparency layer of the verification framework, completing the quartet after the exosome sourcing piece (allogeneic product transparency), the stem cell volume piece (procedural infrastructure), and the PRP preparation piece (autologous product transparency). Same logic applied to the IV product: what's actually in the bag, where did it come from, who verified it, and what is the clinical indication that justifies the dose and the route?

If you have been told "we'll do an IV today," that is not yet a clinical specification. It is the start of one. The questions in this article complete it.

The Medical IV Therapy Spectrum at a Regenerative Clinic

The IV protocols that have a clinical place at a regenerative medicine clinic in Medellín are a finite list, each with documented indications, dose ranges, infusion durations, and pre-screening requirements. These are not "wellness drips" in the marketing sense. They are clinical interventions that happen to use the IV route.

The major protocols and their typical clinical roles:

1. NAD+ IV — Nicotinamide adenine dinucleotide, a coenzyme central to cellular energy metabolism (Krebs cycle, electron transport chain, sirtuin activity, PARP activity). IV NAD+ is used for cellular energy and longevity-adjacent indications, post-substance-use recovery in some protocols, and as an adjunct in the Stem Cell Express regenerative protocol. Typical session dose ranges from 250 mg to 1000 mg per infusion; the 500 mg dose is common for non-clinical wellness use; higher doses (750–1000 mg) for specific indications. Critical: NAD+ must be infused slowly — typical infusion duration 2–4 hours per session, and sometimes longer at higher doses. Faster infusion produces a strong adverse reaction (chest tightness, abdominal cramping, flushing, nausea). The slow drip rate is not optional; it is the safety standard.

2. Myers Cocktail — A multi-component IV containing magnesium, calcium, B-complex vitamins, vitamin B12 (methylcobalamin or hydroxocobalamin), and vitamin C in moderate doses. The protocol originated with Dr. John Myers and is documented for migraine, fatigue, fibromyalgia, asthma, and acute infection adjunct indications. Typical infusion duration 30–60 minutes. Generally well tolerated.

3. High-Dose Vitamin C IV — Vitamin C (sodium ascorbate) at doses substantially higher than oral can deliver. Typical dose ranges from 7.5 g to 50 g, with higher doses (50–100 g) used in specific oncology-adjunct protocols under specialist supervision. Used for antioxidant, immune support, and oncology-adjunct indications. Critical pre-screening: G6PD (glucose-6-phosphate dehydrogenase) status must be verified before high-dose vitamin C IV. Patients with G6PD deficiency are at risk of oxidative hemolysis at high doses. Renal function should also be verified given the oxalate metabolite consideration. Infusion duration depends on dose; higher doses are infused over hours.

4. Glutathione IV — Reduced glutathione, the major intracellular antioxidant. Used in some protocols as part of hydration and nutrient support; a clinician can explain its intended role, evidence, and risks. Typical dose 600–1200 mg, sometimes higher. Often paired with vitamin C IV. Infusion duration typically 15–45 minutes. Generally well tolerated.

5. Amino Acid IV — Compounded amino acid blends used for athletic recovery, muscle support, and some catabolic-state recovery indications. Typical compositions include BCAAs (leucine, isoleucine, valine), glutamine, arginine, and other amino acids. Compositions vary by clinic and indication. Infusion duration typically 45–90 minutes.

6. Phosphatidylcholine IV — Lipid-based IV preparation used in cognitive support, hepatic membrane repair, and specific lipid-modulating protocols. Typical dose 1000–2500 mg. Infusion duration typically 60–90 minutes given slowly. Less common than the other protocols and used for specific indications.

7. Chelation IV — EDTA (ethylenediaminetetraacetic acid) IV chelation for documented heavy metal burden (lead, arsenic, mercury, cadmium). Critical: chelation requires documented metal burden via appropriate testing, cardiac evaluation, renal function evaluation, and informed consent regarding the controversies around non-FDA-approved chelation indications. Not appropriate as a routine wellness drip. Typical infusion duration 90 minutes to 3 hours per session, with multiple sessions over weeks to months.

8. Hydration and Electrolyte IV — Saline or lactated Ringer's with electrolyte adjustment for documented dehydration, post-procedure recovery, post-flight or altitude-adjacent dehydration, or as part of a multi-day medical tourism protocol. The most clinically straightforward IV. Infusion duration typically 30–60 minutes.

Specifically not on this list at a serious regenerative clinic: anything marketed primarily as a "hangover drip" for nightlife recovery without clinical indication. The same components (saline, B-complex, antiemetic) may have a clinical place when there is a clinical indication; the marketing positioning is what differs.

What's Actually in Each Protocol — Typical Compositions

Below is a descriptive snapshot of typical compositions for the most-administered medical IV protocols. Specific protocols vary by clinic, by indication, by patient status, and by compounding pharmacy supply.

Myers Cocktail (representative composition)

• Magnesium sulfate 1–2 g
• Calcium gluconate 100–200 mg
• B-complex (thiamine, riboflavin, niacinamide, pantothenic acid, pyridoxine) 1–2 mL
• Vitamin B12 (methylcobalamin or hydroxocobalamin) 1000 mcg
• Vitamin C (sodium ascorbate) 1–5 g
• In sterile saline or sterile water, total volume typically 100–250 mL
• Infusion duration: 30–60 minutes

NAD+ IV (representative composition)

• NAD+ (nicotinamide adenine dinucleotide) 250–1000 mg per session
• In sterile saline, total volume typically 500 mL
• Infusion duration: 2–4 hours, sometimes longer at higher doses
• Adjunct: sometimes paired with B-complex or methyl donor support

High-Dose Vitamin C IV (representative composition)

• Vitamin C (sodium ascorbate, preservative-free) 7.5–50 g per session, with higher doses for specific protocols
• In sterile saline or sterile water, total volume varies with dose
• Infusion duration: minimum 1 hour for moderate doses; 2–4 hours for high doses
• Required pre-screening: G6PD status, renal function

Glutathione IV (representative composition)

• Reduced glutathione 600–1200 mg
• In sterile saline, total volume typically 50–100 mL
• Infusion duration: 15–45 minutes
• Often paired post-vitamin-C in some protocols

Amino Acid IV (representative composition, varies)

• BCAAs (leucine, isoleucine, valine) variable mg
• Glutamine variable mg
• Arginine variable mg
• Other amino acids per protocol
• In sterile saline, total volume 250–500 mL
• Infusion duration: 45–90 minutes

The above are descriptive snapshots only. Specific compositions and doses must be determined by the prescribing physician based on the patient's clinical status, indication, lab values, and concurrent therapies.

Compounding Pharmacy Verification: The IV Equivalent of Lot Traceability

The exosome sourcing article asked a single dominant question of any allogeneic biological product: who manufactured it, where, with what quality system? IV therapy raises the same question.

Most clinical IV preparations are not pre-packaged proprietary products. They are compounded — meaning the constituent ingredients (NAD+, vitamin C, glutathione, amino acids, etc.) are sourced from specific suppliers, then combined and packaged into the final IV bag at a compounding pharmacy. The quality of the final IV product depends on the quality of the constituent ingredients, the compounding-pharmacy process, the sterility validation, and the chain of custody from compounding to administration.

A serious regenerative clinic in Medellín:

• Sources compounded IV preparations from INVIMA-registered compounding pharmacies (the Colombian equivalent of FDA-registered compounding facilities).
• Documents the specific compounding pharmacy by name, with INVIMA registration available on request.
• Maintains lot-level traceability for each compounded preparation.
• Documents the ingredient source (the manufacturer of the raw NAD+, the manufacturer of the raw vitamin C, etc.) for each compounded protocol.
• Verifies sterility validation for each compounded batch.
• Stores compounded preparations under appropriate conditions (refrigeration where indicated, light-protected for vitamin C, etc.).
• Documents expiration dating appropriate to the compounded product.

A clinic that cannot name the compounding pharmacy, cannot produce INVIMA registration on request, cannot identify the ingredient source, and cannot show lot-level traceability is administering a product they have not characterized. The same red-flag logic that applies to exosomes applies here.

The Eight Bedside IV Questions

These take five minutes at a serious practice. Ask all eight before any IV administration.

1. Which compounding pharmacy is the source for this preparation? Is it INVIMA-registered?

Acceptable answer: a specific named compounding pharmacy with available INVIMA registration documentation. "We just buy from a wholesaler" is not an answer.

2. What is the lot number of this specific preparation? Where is the lot-traceability documentation?

Acceptable answer: a specific lot number documented in your record.

3. What are the constituent ingredients and their source? What is the dose of each?

Acceptable answer: a specific itemized list with doses and sources for the active components.

4. What is the sterility validation for this batch? What is the expiration date?

Acceptable answer: documented sterility validation and a clear expiration date within the appropriate window.

5. What is the clinical indication for this specific protocol in my case? What is the dosing rationale?

Acceptable answer: a specific clinical indication and dosing rationale linked to the patient's presentation, lab values, or treatment plan. "It's good for everything" is a red flag.

6. What is the planned drip rate and total infusion duration? Are you adjusting for my body size and clinical status?

Acceptable answer: a specific drip rate and infusion duration appropriate to the protocol (NAD+ 2–4 hours, high-dose vitamin C 1–4 hours depending on dose, Myers Cocktail 30–60 minutes, etc.).

7. What pre-screening labs have been done? Specifically: G6PD status if high-dose vitamin C is on the protocol, renal function for NAD+ or high-volume protocols, cardiac history for chelation?

Acceptable answer: documented pre-screening appropriate to the specific protocol.

8. Who is the named medical responsibility for this IV? Where is the adverse-event tracking system? What is the historical adverse event rate for this protocol at this clinic?

Acceptable answer: a named physician with medical responsibility, a documented adverse event tracking system, and a willingness to disclose the rate. "We've never had any problems" is a red flag for the same reason as in the volume verification framework — at any meaningful procedural volume, that statement is statistically implausible, and a clinic without tracking would have no way of knowing.

Pre-Screening: G6PD, Renal, and Cardiac

Three pre-screening requirements deserve specific attention because they are most often skipped:

G6PD pre-screening for high-dose vitamin C IV

G6PD (glucose-6-phosphate dehydrogenase) is an enzyme involved in red blood cell oxidative defense. G6PD deficiency is the most common enzymatic disorder of red blood cells worldwide, with higher prevalence in patients of Mediterranean, African, Middle Eastern, and Southeast Asian heritage. High-dose vitamin C IV can precipitate oxidative hemolysis in G6PD-deficient patients. The pre-screening is a standard lab test. A clinic that administers high-dose vitamin C IV without G6PD documentation is bypassing a known safety standard.

Renal pre-screening for NAD+ and high-volume protocols

Patients with reduced renal function may have altered clearance of IV components and reduced tolerance of fluid volume loads. Baseline creatinine and eGFR should be documented before NAD+ IV (especially at higher doses) and before any high-volume IV protocol. The pre-screening is a standard lab test.

Cardiac history pre-screening for chelation

EDTA chelation is associated with electrolyte shifts (especially calcium) and has been associated in older case literature with cardiac arrhythmias when administered improperly. Baseline cardiac history and, where appropriate, ECG should be documented before chelation. Chelation should not be administered as a routine wellness drip without indication, pre-screening, and informed consent.

How IV Sits in the Combined-Protocol Architecture (Stem Cell Express)

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

• Day 1 IV — Hydration and electrolyte support, often paired with a Myers Cocktail base, to optimize circulating volume status before the adipose mini-liposuction and the systemic stem cell administration.
• Days 2–4 IVs — Sequenced to support the regenerative protocol: NAD+ IV for cellular energy substrate during the post-injection regenerative window, glutathione IV for oxidative stress management, vitamin C IV (after G6PD verification) for antioxidant and immune support, and amino acid IV where indicated for catabolic recovery.
• Day 5 IV — Often a final hydration plus targeted nutritional support to optimize the patient's status before flight home.

The IV sequencing is not arbitrary. It is matched to the regenerative timeline so that the IV-delivered substrate supports the regenerative protocol rather than running parallel to it. For the full regenerative sequencing detail, see the Combined Peptide + Stem Cell Therapy: The Clinical Sequencing Guide (2026).

Red Flags in IV Therapy

• Cannot name the compounding pharmacy.
• Cannot produce INVIMA registration on request.
• Cannot itemize the constituent ingredients and their sources.
• No lot number documentation.
• No sterility validation framework.
• No expiration dating documentation.
• Same protocol for every patient regardless of indication or lab status.
• No G6PD pre-screening before high-dose vitamin C.
• No renal pre-screening before NAD+ or high-volume protocols.
• No cardiac pre-screening before chelation.
• Drip rate too fast for the protocol (NAD+ infused in under 60 minutes, high-dose vitamin C infused in under 1 hour at high doses).
• Marketing positioning emphasizes "hangover" or "nightlife recovery" rather than clinical indication.
• No adverse event tracking.
• "We've never had any problems."
• Mobile-only service with no clinical infrastructure.
• IV administered by non-clinical personnel.

Who Is and Is NOT a Candidate for Various IV Protocols

Generally appropriate (with indication and pre-screening)

• Adults with documented clinical indication for a specific IV protocol.
• Patients in a multi-day regenerative protocol (Stem Cell Express or a la carte combined) where IV therapies are sequenced as a component.
• Patients with documented oxidative-stress or specific nutritional indications appropriate to the protocol.
• Patients seeking peri-procedural support (hydration, electrolyte balance) within an indicated framework.

NOT candidates (generally)

• Active untreated infection at the IV access site.
• Severe renal impairment without specialist consultation.
• Severe heart failure with fluid restriction (high-volume IV protocols).
• G6PD deficiency for high-dose vitamin C IV (the protocol must be modified or substituted).
• Active malignancy: case-by-case; some IV protocols are oncology-adjunct, others may not be appropriate without oncology coordination.
• Pregnancy and breastfeeding: case-by-case based on the specific protocol.
• Patients with anaphylactic-grade allergies to any IV component (the offending component must be excluded or the protocol substituted).
• Patients seeking IV for mobile hangover recovery without clinical indication — this is a different product category from medical IV therapy.

Frequently Asked Questions

1. Are mobile hangover IV services in Medellín dangerous?

Not necessarily dangerous in every case, but they are a different product category from medical IV nutritional therapy. The clinical infrastructure (compounding source verification, pre-screening, drip-rate protocols, adverse event tracking) is generally not present. Patients seeking medical-grade IV therapy as part of a wellness or regenerative protocol should look at clinical regenerative practices, not mobile hangover services.

2. Why does NAD+ IV take 2–4 hours when other IVs take 30 minutes?

Faster NAD+ infusion produces a strong adverse reaction including chest tightness, abdominal cramping, flushing, and nausea. The slow drip rate is the safety standard, not an inefficiency. Clinics that infuse NAD+ rapidly to "save time" are exposing patients to a known adverse reaction.

3. Can I get high-dose vitamin C IV without a G6PD test?

You should not. G6PD deficiency carries a known risk of oxidative hemolysis at high vitamin C doses. The G6PD test is a standard lab and the result is binary (normal or deficient). Clinics that administer high-dose vitamin C without G6PD verification are bypassing a safety standard.

4. What is the difference between Myers Cocktail and a "vitamin drip"?

The Myers Cocktail is a specific protocol with documented composition (magnesium, calcium, B-complex, B12, vitamin C) and documented indications. "Vitamin drip" without further specification is a marketing term that may or may not correspond to a specific protocol. Ask for the specific composition.

5. Is IV chelation appropriate for general "detox"?

No. Chelation is appropriate for documented heavy metal burden via appropriate testing, with appropriate cardiac and renal pre-screening. It is not appropriate as a routine wellness or detox drip. Patients seeking "detox" without documented metal burden should consider that the appropriate intervention is generally not chelation.

6. Do I need to have an IV at YouMedicine to do the Stem Cell Express?

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

7. Can I bring my own IV components from a U.S. compounding pharmacy?

Generally not appropriate. IV components have specific storage, sterility, and chain-of-custody requirements that are difficult to maintain in transit. The clinic's compounding source is the appropriate supply chain.

8. How often can I do NAD+ IV?

Indication-dependent. Some protocols use a loading series (3–5 sessions in 1–2 weeks) followed by maintenance every 1–3 months. Other protocols are single-session adjuncts to a broader regenerative protocol. The frequency should be matched to the indication, not standardized.

9. Can I do IV therapy if I am on TRT, GLP-1, or HRT?

Generally yes, with no specific contraindication for these therapies. The pre-screening still applies (G6PD for high-dose vitamin C, renal function for NAD+ and high-volume).

10. Is glutathione IV worth it for skin?

The literature on IV glutathione for skin brightening is mixed. There is more robust support for IV glutathione in oxidative stress and hepatic protection contexts. Patients seeking IV glutathione specifically for skin brightening should set realistic expectations and consider that the more robust skin interventions are topical, microneedling-based, and aesthetic-procedure-based.

11. What is the difference between IV and IM (intramuscular) administration of B12, glutathione, etc.?

IV delivers the dose into the bloodstream directly with rapid distribution. IM delivers into muscle with slower absorption. IV is appropriate for higher doses, faster onset, and protocols requiring specific blood-level kinetics. IM is appropriate for routine maintenance dosing of products like B12. The choice should match the indication.

12. How do I know the IV was actually administered as documented?

Ask for the IV bag label to be retained in your record (or photographed at the start of administration). Ask for the start time, drip rate, and end time to be documented. Ask for the lot number to be in your record. Documentation is the protection.

Cross-Linked Companion Guides

• Exosome Therapy in Colombia — What's Actually in That Vial? (2026) — first leg of the verification framework (allogeneic product transparency).
• Volume Beats Credentials: The 2026 Stem Cell Clinic Verification Framework Beyond Credentials (2026) — second leg (procedural infrastructure).
• PRP Variability — What's Actually in Your Tube? (2026) — third leg (autologous product transparency).
• Combined Peptide + Stem Cell Therapy: The Clinical Sequencing Guide (2026) — for how IV therapies sequence with the regenerative components.
• Cost-Per-Result: When PRP Beats Exosomes Beats Stem Cells (2026) — for the buyer's economic decision framework.
• Verifying Your Medellín Peptide Clinic on Day 1 (2026) — for the binary credential verification.
• Peptide Therapy in Colombia: INVIMA Standards, Safety & Regulations (2026) — for the INVIMA framework that governs compounded preparations.

Who This Article Is NOT For

• Patients seeking same-day mobile hangover IV without clinical indication.
• Patients unwilling to ask the eight bedside IV questions.
• Patients seeking IV chelation as routine "detox" without documented metal burden.
• Patients seeking guarantees from any IV protocol.
• Patients who view IV pre-screening (G6PD, renal, cardiac) as inconvenient bureaucracy rather than safety standard.

The Bottom Line

Medical IV therapy at a regenerative clinic and mobile hangover IV are not the same product category. They share a delivery route. They differ in compounding source, pre-screening, drip-rate protocol, indication discipline, and adverse-event tracking infrastructure.

The eight bedside IV questions take five minutes at a serious practice and produce immediate clarity at a practice that has not built the documentation infrastructure. Verification protects you and gets you the product you are paying for.

Ask which compounding pharmacy. Ask for the lot number. Ask for the ingredient source. Ask about sterility. Ask about the indication and dosing rationale. Ask about the drip rate and infusion duration. Ask about pre-screening. Ask who has named medical responsibility and where the adverse-event tracking is. Five minutes. Five minutes determines whether you are receiving medical IV nutritional therapy or an undocumented preparation labeled with the same word.

Schedule a Consultation

YouMedicine in El Poblado, Medellín administers medical IV nutritional therapy with full documentation: INVIMA-registered compounding pharmacy source, lot-level traceability, ingredient source documentation, sterility validation, indication-specific dosing rationale, protocol-appropriate drip rate and infusion duration, G6PD pre-screening before high-dose vitamin C, renal pre-screening before NAD+ and high-volume protocols, cardiac pre-screening before chelation, and adverse event tracking infrastructure.

• Email: wellness@youmedicine.co
• WhatsApp: +57 324 576 1913
• Location: El Poblado, Medellín, Colombia

In your first message, request:

• The specific IV protocols available with composition, dose ranges, and infusion duration documentation
• The compounding pharmacy source with INVIMA registration documentation
• The pre-screening labs we will need before administration of any protocol on your indication list

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

• The adverse event tracking and historical rate for your specific protocol of interest

We will provide the documentation in advance so the bedside verification work happens before the IV bag is hung, not after.

YouMedicine — El Poblado, Medellín. Wellness starts with YOU.